According to a press release, Miach Orthopaedics Inc. announced that it has closed a $40 million financing round in order to increase commercialization of its bridge-enhanced ACL reconstruction implant in the United States.
Financing for expanded commercialization of the bridge-enhanced ACL restoration (BEAR) implant was provided by equity from the following investors: Sectoral Asset Management, Endeavour Vision, Amzak Health, Smith & Nephew, DSM Venturing and the NFL Players Association, according to the release.
“Since launching our BEAR implant in fall 2021, we’ve received
